FreeAgent 6eab0ea5d4f2f1cf7fac45052a78856b0b521e0a false No description of principal activity 18 February 2023 29 February 2024 146731802023-02-182024-02-29 14673180uk-bus:Director12023-02-182024-02-29 14673180uk-bus:AuditExempt-NoAccountantsReport2023-02-182024-02-29 14673180uk-bus:Micro-entities2023-02-182024-02-29 14673180uk-bus:FullAccounts2023-02-182024-02-29 14673180uk-bus:PrivateLimitedCompanyLtd2023-02-182024-02-29 14673180uk-bus:RegisteredOfficeuk-countries:UnitedKingdom2023-02-182024-02-29 146731802023-02-18 146731802024-02-29 14673180uk-core:CurrentFinancialInstruments2024-02-29 14673180uk-core:Non-currentFinancialInstruments2024-02-29 iso4217:GBP xbrli:pure

NM Biopharma Ltd

Unaudited financial statements for the period from 18 February 2023 to 29 February 2024


Company information

NM Biopharma Ltd is a private company limited by shares, registered in England and Wales, registered number 14673180.

The company's registered office is: Ground Floor Vista, St David's Park, Ewloe, Deeside, CH5 3DT, United Kingdom.

Balance Sheet

as at 29 February 2024

13 months to
29 Feb 24
£ £
Current assets 65,795.82
Creditors: amounts falling due within one year (25,411.05)
Net current assets / (liabilities) 40,384.77
Total assets less current liabilities 40,384.77
Net assets 40,384.77
Capital and reserves 40,384.77

For the period from 18 February 2023 to 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Directors' responsibilities:

Approved by the board of directors and signed on behalf of the board,

Natalie Marshall
17 April 2024

Notes to the accounts

  1. Average number of employees

    During the period the average number of employees was 1.